Full Text

Turn on search term navigation

© 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.

Abstract

Objective: To evaluate the influence of conventional rehabilitation combined with virtual reality on improving quality of life related to post-stroke health. Design: Randomized controlled trial. Setting: Rehabilitation and neurology departments of a general hospital (Talavera de la Reina, Spain). Subjects: A total of 43 participants with subacute stroke. Intervention: Participants were randomized into experimental group (conventional treatment + virtual reality) and control (conventional treatment). Main measures: Health-related quality of life as measured by the EuroQoL-5 dimensions instrument (EQ-5D-5L) and EuroQoL visual analog scale (EQ-VAS). Results: A total of 23 patients in the experimental group (62.6 ± 13.5 years) and 20 in the control (63.6 ± 12.2 years) completed the study. In the experimental group, EQ-VAS score was 29.1 ± 12.8 at baseline, 86.5 ± 7.1 post-intervention, and 78.3 ± 10.3 at the three-month follow-up. The control group obtained scores of 25.5 ± 5.1, 57.0 ± 4.7, and 58.5 ± 5.9, respectively. We identified significant differences at the post-intervention and follow-up timepoints (p = 0.000) and a partial η2 of 0.647. In EQ-5D-5L, the severity of issues decreased after intervention in the experimental group, while pain and anxiety dimensions increased between post-intervention and follow-up. Conclusions: The conventional rehabilitative approach combined with virtual reality appears to be more effective for improving the perceived health-related quality of life in stroke survivors.

Details

Title
Effects of Virtual Reality-Based Therapy on Quality of Life of Patients with Subacute Stroke: A Three-Month Follow-Up Randomized Controlled Trial
Author
Rodríguez-Hernández, Marta 1   VIAFID ORCID Logo  ; Criado-Álvarez, Juan-José 2   VIAFID ORCID Logo  ; Ana-Isabel Corregidor-Sánchez 1   VIAFID ORCID Logo  ; Martín-Conty, José L 1   VIAFID ORCID Logo  ; Mohedano-Moriano, Alicia 1   VIAFID ORCID Logo  ; Polonio-López, Begoña 1   VIAFID ORCID Logo 

 Faculty of Health Sciences, University of Castilla La Mancha, 45600 Talavera de la Reina, Spain; [email protected] (M.R.-H.); [email protected] (A.-I.C.-S.); [email protected] (J.L.M.-C.); [email protected] (A.M.-M.); [email protected] (B.P.-L.); Technological Innovation Applied to Health Research Group (ITAS), Faculty of Health Sciences, University of Castilla La Mancha, 45600 Talavera de la Reina, Spain 
 Faculty of Health Sciences, University of Castilla La Mancha, 45600 Talavera de la Reina, Spain; [email protected] (M.R.-H.); [email protected] (A.-I.C.-S.); [email protected] (J.L.M.-C.); [email protected] (A.M.-M.); [email protected] (B.P.-L.); Technological Innovation Applied to Health Research Group (ITAS), Faculty of Health Sciences, University of Castilla La Mancha, 45600 Talavera de la Reina, Spain; Department of Public Health, Institute of Health Sciences, 45600 Talavera de la Reina, Spain 
First page
2810
Publication year
2021
Publication date
2021
Publisher
MDPI AG
ISSN
1661-7827
e-ISSN
1660-4601
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2628159611
Copyright
© 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.